Residency · Residency · Vascular Surgery
Carotid Endarterectomy: Indications, Technique, and Outcomes
Overview
Carotid endarterectomy (CEA) is a surgical procedure that involves the removal of atherosclerotic plaque from the carotid bifurcation. It is one of the most extensively studied operations in surgery, supported by multiple landmark randomized trials. CEA effectively reduces the risk of stroke in both symptomatic patients and selected asymptomatic individuals who have significant carotid stenosis. In the United States alone, over 100,000 CEAs are performed annually. To demonstrate a clear benefit, the perioperative stroke and death rate must be kept below 6% for symptomatic disease and below 3% for asymptomatic disease.
Landmark Trials
Symptomatic Disease
The North American Symptomatic Carotid Endarterectomy Trial (NASCET) conducted in 1991 compared CEA plus medical therapy to medical therapy alone in patients with symptomatic carotid stenosis. For those with 70-99% stenosis, the absolute risk reduction (ARR) in stroke at two years was 17%, corresponding to a number needed to treat (NNT) of 6. Patients with 50-69% stenosis experienced a smaller benefit, with an ARR of 6.5% at five years (NNT = 15). No benefit was observed in patients with less than 50% stenosis. The European Carotid Surgery Trial (ECST) in 1998 confirmed the benefit of CEA for symptomatic stenosis greater than 70%, using a measurement method roughly equivalent to NASCET’s 50% threshold.
Asymptomatic Disease
In asymptomatic patients, the Asymptomatic Carotid Atherosclerosis Study (ACAS) in 1995 demonstrated that CEA reduced the five-year stroke risk from 11% to 5.1%, an ARR of 5.9%, in patients with stenosis of 60% or greater. The Asymptomatic Carotid Surgery Trial-1 (ACST-1) in 2010 showed that CEA halved the 10-year stroke risk, reducing it from 17.9% to 13.4%. However, the benefit in asymptomatic disease is smaller and depends heavily on maintaining low perioperative complication rates.
Important Caveats
It is important to note that all these trials were conducted using medical therapy standards from the 1990s. Since then, advances in optimal medical therapy—including high-intensity statins, blood pressure control, and antiplatelet agents—may have lowered the baseline stroke risk in asymptomatic patients. Current trials such as CREST-2 and ACST-2 are investigating the comparative effectiveness of intervention versus modern medical therapy in asymptomatic disease.
Indications
Strong Indications (Level I Evidence)
CEA is strongly indicated for symptomatic stenosis of 50% or greater, measured by the NASCET method, provided the perioperative stroke and death rate is below 6%. The greatest benefit is seen in patients with 70-99% stenosis, and urgent surgery within two weeks of the index event is recommended to maximize stroke risk reduction. For asymptomatic stenosis of 60-70% or greater, CEA can also be beneficial if the perioperative complication rate is under 3%. However, the benefit is smaller than in symptomatic disease, and patients must have a life expectancy of at least three to five years to realize this benefit. Careful patient selection is therefore critical.
Relative Indications
CEA may be considered in asymptomatic patients with high-risk plaque features such as echolucency, ulceration, or progressive stenosis. It is also considered in cases of contralateral internal carotid artery (ICA) occlusion with ipsilateral symptomatic stenosis and, more controversially, in patients undergoing pre-cardiac surgery who have carotid stenosis.
Contraindications
CEA is contraindicated in patients with chronic total ICA occlusion, as there is no benefit and the risk outweighs any potential gain. It is also not recommended in patients with severe neurologic deficits from completed stroke where there is no viable brain territory to protect. Patients with very high surgical risk who have favorable anatomy for carotid artery stenting (CAS) or transcarotid artery revascularization (TCAR) should avoid CEA. Additionally, limited life expectancy of less than three years in asymptomatic disease negates the benefit of surgery.
<image>Summary diagram of CEA indications based on landmark trial data, showing symptomatic and asymptomatic stenosis thresholds, required perioperative complication rates, and corresponding absolute risk reductions with NNT values for each category</image>
Surgical Technique
Standard (Conventional) CEA
The patient is positioned supine with the head turned to the contralateral side and the neck extended. The skin incision is made along the anterior border of the sternocleidomastoid muscle (SCM). After dividing the platysma, the SCM is retracted laterally to expose the carotid sheath. Key nerves are identified and preserved, including the vagus nerve located posterior to the ICA, the hypoglossal nerve which crosses the ICA superiorly, and the marginal mandibular branch of the facial nerve.
Dissection proceeds to expose the common carotid artery (CCA), carotid bifurcation, internal carotid artery (ICA), and external carotid artery (ECA). Careful dissection is essential to avoid plaque disruption and embolization. Systemic heparinization is administered intravenously at 80-100 units per kilogram before vascular clamping. Clamping is performed in sequence: first the ICA, then the ECA, and finally the CCA, which helps prevent embolization.
A longitudinal arteriotomy is made extending from the CCA across the bifurcation into the ICA. If a shunt is used, it is placed at this stage; common types include the Javid, Pruitt-Inahara, or Argyle shunts. The endarterectomy involves developing the plane between the plaque and the outer media or adventitia. The plaque in the CCA is sharply divided with a clean proximal endpoint, while the distal endpoint in the ICA is feathered to avoid creating a shelf or intimal flap. Plaque is everted from the ECA orifice. If the distal ICA endpoint is not smooth, tacking sutures are placed to secure the intima.
Closure can be performed primarily or with patch angioplasty, with patch closure generally preferred. Unclamping is done in reverse order: the ECA is released first to flush debris, followed by the ICA and then the CCA.
Eversion CEA
In eversion CEA, the ICA is transected at its origin from the carotid bulb and turned inside-out to remove the plaque. The ICA is then re-anastomosed to the CCA. This technique preserves the natural tapering of the vessel and eliminates the need for a patch. However, it is less suitable for long plaques and does not allow easy use of a shunt.
Patch Closure
Patch angioplasty reduces perioperative stroke, restenosis, and ICA occlusion compared to primary closure. Common patch materials include Dacron (the most frequently used), polytetrafluoroethylene (PTFE), bovine pericardium, and, less commonly, autogenous vein. Randomized trials support the superiority of patch closure over primary closure.
Shunting
Shunting during CEA can be routine, selective, or omitted. Routine shunting involves placing a shunt in all patients to maintain cerebral perfusion, which proponents argue is simple and safe. Selective shunting is based on cerebral monitoring that detects ischemia during cross-clamping; criteria include electroencephalography (EEG) changes, stump pressure below 40-50 mmHg, transcranial Doppler (TCD) flow reduction, or neurologic changes in awake patients. Some surgeons opt for no shunting, accepting brief ischemia, which is tolerated by most patients but carries some risk. There is no definitive randomized data proving the superiority of any particular approach.
Cerebral Monitoring During CEA
Several modalities are used to monitor cerebral perfusion during CEA. Electroencephalography (EEG) detects hemispheric ischemia but requires a neurophysiology team. Stump pressure measures the back-pressure in the ICA after clamping; values below 40-50 mmHg suggest inadequate collateral flow. Transcranial Doppler (TCD) monitors flow velocity in the middle cerebral artery and can detect emboli and flow reductions. Regional anesthesia with an awake patient provides the best real-time monitoring by allowing direct neurologic assessment during clamping. Near-infrared spectroscopy (NIRS) measures cerebral oxygenation but is less validated.
<image>Step-by-step surgical illustration of standard carotid endarterectomy showing (A) skin incision along the SCM, (B) exposure of the carotid bifurcation with labeled cranial nerves, (C) arteriotomy with plaque visible, (D) endarterectomy with plaque removal in the correct plane, (E) distal intimal endpoint, and (F) Dacron patch closure</image>
Perioperative Management
Preoperative
Antiplatelet therapy, typically aspirin, is continued through surgery. High-intensity statin therapy is initiated or maintained, and blood pressure is optimized to avoid extremes. Recent imaging is essential to confirm the degree of stenosis and assess the contralateral carotid artery.
Intraoperative
Blood pressure management aims to avoid hypotension, which increases stroke risk, and hypertension, which can cause hemorrhage or hyperperfusion syndrome. Completion assessment is performed using duplex ultrasound, completion angiography, or angioscopy to identify residual plaque, intimal flaps, thrombus, or technical defects. Any significant findings should be corrected before leaving the operating room.
Postoperative
Patients are monitored in an intensive care unit or a closely observed bed for 12 to 24 hours. Neurologic checks are performed every one to two hours. Blood pressure is carefully monitored to maintain normotension; hypertension increases the risk of hyperperfusion syndrome and wound hematoma, while hypotension raises the risk of stroke due to thrombosis. Aspirin is continued postoperatively, and some protocols add clopidogrel for one to three months. Duplex ultrasound surveillance is performed at one month, six months, and then annually.
Complications
Perioperative stroke occurs in 1-3% of cases when performed by experienced surgeons, and rates must remain below 6% for symptomatic and below 3% for asymptomatic patients to justify surgery. Cranial nerve injury occurs in 5-8% of patients, most of which are transient. The hypoglossal nerve injury causes tongue deviation toward the affected side, vagus or recurrent laryngeal nerve injury results in hoarseness, marginal mandibular nerve injury causes mouth droop, and greater auricular nerve injury leads to ear numbness, which is the most common and often permanent.
Neck hematoma occurs in 3-5% of cases and may require emergent reoperation if it compromises the airway. Hyperperfusion syndrome, characterized by headache, seizures, or intracerebral hemorrhage, occurs when a chronically hypoperfused brain is suddenly reperfused. Risk factors include severe bilateral stenosis, recent stroke, and poorly controlled hypertension. Prevention involves strict postoperative blood pressure control, maintaining systolic blood pressure below 140-150 mmHg. Myocardial infarction occurs in 1-2% of patients. Restenosis can occur early (within two years) due to intimal hyperplasia or late (after two years) due to recurrent atherosclerosis.
Clinical Pearls
Timely intervention is critical because "time is brain"; symptomatic carotid stenosis should be treated within two weeks of the index event to minimize stroke risk. Patch closure is superior to primary closure and is well established as the preferred technique. It is essential to confirm that the distal ICA endpoint is smooth and free of any shelf or intimal flap, as this is the most common cause of perioperative stroke. Cranial nerve injuries are usually transient, but patients should be counseled about this risk preoperatively. Hyperperfusion syndrome is preventable with strict blood pressure control, maintaining systolic blood pressure below 140-150 mmHg after surgery. Completion imaging is essential to detect and correct technical problems before leaving the operating room. Finally, the benefit of CEA for asymptomatic disease is modest and depends heavily on maintaining low perioperative complication rates, making the surgeon’s experience and track record critical factors.
References
- NASCET Collaborators. Beneficial effect of CEA in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445-453.
- ACAS Executive Committee. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
- Ricotta JJ, et al. Updated SVS guidelines for management of extracranial carotid disease. J Vasc Surg. 2011;54(3):e1-e31.
- Naylor AR, et al. ESVS 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg. 2023;65(1):7-111.
- Bond R, et al. Systematic review of randomized controlled trials of patch angioplasty during carotid endarterectomy. Stroke. 2004;35(12):2960-2966.
